GPR50 and major depressive disorder: The first case–control study of 226 patients with MDD and 562 ethnically matched controls found that two GPR50 polymorphisms (rs13440581 and Δ502–505) were strongly associated with an increased risk of MDD in women (Thomson et al. 2005).